関節リウマチ治療の世界市場（～2026年）

• 英文タイトル：Global Rheumatoid Arthritis Treatment Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY04516
• 出版社/出版日：QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、99ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料は関節リウマチ治療のグローバル市場について調査・分析したレポートです。種類別（対症療法、中間コルチコステロイド療法、疾患修飾性抗リウマチ薬療法）市場規模、用途別（病院薬局、小売薬局、ドラッグストア）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別関節リウマチ治療の競争状況、市場シェア
・世界の関節リウマチ治療市場：種類別市場規模 2015年-2020年（対症療法、中間コルチコステロイド療法、疾患修飾性抗リウマチ薬療法）
・世界の関節リウマチ治療市場：種類別市場規模予測 2021年-2026年（対症療法、中間コルチコステロイド療法、疾患修飾性抗リウマチ薬療法）
・世界の関節リウマチ治療市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、ドラッグストア）
・世界の関節リウマチ治療市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、ドラッグストア）
・北米の関節リウマチ治療市場分析：米国、カナダ
・ヨーロッパの関節リウマチ治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの関節リウマチ治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の関節リウマチ治療市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの関節リウマチ治療市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Sanofi、Pfizer、Roche、Johnson & Johnson、AbbVie、Eli Lilly、Amgen、Sobi、Bristol-Myers Squibb
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Rheumatoid arthritis is a long-term autoimmune disorder that primarily affects joints.
The rheumatoid arthritis treatment market is expected to grow over the forecast period owing to the high incidence rate of rheumatoid arthritis among people.

Market Analysis and Insights: Global Rheumatoid Arthritis Treatment Market
The global Rheumatoid Arthritis Treatment market size is projected to reach US$ 7504.7 million by 2026, from US$ 7259.9 million in 2020, at a CAGR of 3.1%% during 2021-2026.

Global Rheumatoid Arthritis Treatment Scope and Market Size
Rheumatoid Arthritis Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Rheumatoid Arthritis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Sanofi
Pfizer
Roche
Johnson & Johnson
AbbVie
Eli Lilly
Amgen
Sobi
Bristol-Myers Squibb

Market segment by Type, the product can be split into
Symptomatic Treatment
Intermediate Corticosteroid Therapies
Disease Modifying Antirheumatic Drug Therapies
Market segment by Application, split into
Hospital Pharmacy
Retail Pharmacy
Drug Stores

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Rheumatoid Arthritis Treatment Revenue
1.4 Market by Type
1.4.1 Global Rheumatoid Arthritis Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Symptomatic Treatment
1.4.3 Intermediate Corticosteroid Therapies
1.4.4 Disease Modifying Antirheumatic Drug Therapies
1.5 Market by Application
1.5.1 Global Rheumatoid Arthritis Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacy
1.5.3 Retail Pharmacy
1.5.4 Drug Stores
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Rheumatoid Arthritis Treatment Market Perspective (2015-2026)
2.2 Global Rheumatoid Arthritis Treatment Growth Trends by Regions
2.2.1 Rheumatoid Arthritis Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Rheumatoid Arthritis Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Rheumatoid Arthritis Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Rheumatoid Arthritis Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Rheumatoid Arthritis Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Rheumatoid Arthritis Treatment Players by Market Size
3.1.1 Global Top Rheumatoid Arthritis Treatment Players by Revenue (2015-2020)
3.1.2 Global Rheumatoid Arthritis Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Rheumatoid Arthritis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Rheumatoid Arthritis Treatment Market Concentration Ratio
3.2.1 Global Rheumatoid Arthritis Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Rheumatoid Arthritis Treatment Revenue in 2019
3.3 Rheumatoid Arthritis Treatment Key Players Head office and Area Served
3.4 Key Players Rheumatoid Arthritis Treatment Product Solution and Service
3.5 Date of Enter into Rheumatoid Arthritis Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Rheumatoid Arthritis Treatment Historic Market Size by Type (2015-2020)
4.2 Global Rheumatoid Arthritis Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Rheumatoid Arthritis Treatment Market Size by Application (2015-2020)
5.2 Global Rheumatoid Arthritis Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Rheumatoid Arthritis Treatment Market Size (2015-2020)
6.2 Rheumatoid Arthritis Treatment Key Players in North America (2019-2020)
6.3 North America Rheumatoid Arthritis Treatment Market Size by Type (2015-2020)
6.4 North America Rheumatoid Arthritis Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Rheumatoid Arthritis Treatment Market Size (2015-2020)
7.2 Rheumatoid Arthritis Treatment Key Players in Europe (2019-2020)
7.3 Europe Rheumatoid Arthritis Treatment Market Size by Type (2015-2020)
7.4 Europe Rheumatoid Arthritis Treatment Market Size by Application (2015-2020)

8 China
8.1 China Rheumatoid Arthritis Treatment Market Size (2015-2020)
8.2 Rheumatoid Arthritis Treatment Key Players in China (2019-2020)
8.3 China Rheumatoid Arthritis Treatment Market Size by Type (2015-2020)
8.4 China Rheumatoid Arthritis Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Rheumatoid Arthritis Treatment Market Size (2015-2020)
9.2 Rheumatoid Arthritis Treatment Key Players in Japan (2019-2020)
9.3 Japan Rheumatoid Arthritis Treatment Market Size by Type (2015-2020)
9.4 Japan Rheumatoid Arthritis Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Rheumatoid Arthritis Treatment Market Size (2015-2020)
10.2 Rheumatoid Arthritis Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Rheumatoid Arthritis Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Rheumatoid Arthritis Treatment Market Size by Application (2015-2020)

11 India
11.1 India Rheumatoid Arthritis Treatment Market Size (2015-2020)
11.2 Rheumatoid Arthritis Treatment Key Players in India (2019-2020)
11.3 India Rheumatoid Arthritis Treatment Market Size by Type (2015-2020)
11.4 India Rheumatoid Arthritis Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Rheumatoid Arthritis Treatment Market Size (2015-2020)
12.2 Rheumatoid Arthritis Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Rheumatoid Arthritis Treatment Market Size by Type (2015-2020)
12.4 Central & South America Rheumatoid Arthritis Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Sanofi
13.1.1 Sanofi Company Details
13.1.2 Sanofi Business Overview
13.1.3 Sanofi Rheumatoid Arthritis Treatment Introduction
13.1.4 Sanofi Revenue in Rheumatoid Arthritis Treatment Business (2015-2020))
13.1.5 Sanofi Recent Development
13.2 Pfizer
13.2.1 Pfizer Company Details
13.2.2 Pfizer Business Overview
13.2.3 Pfizer Rheumatoid Arthritis Treatment Introduction
13.2.4 Pfizer Revenue in Rheumatoid Arthritis Treatment Business (2015-2020)
13.2.5 Pfizer Recent Development
13.3 Roche
13.3.1 Roche Company Details
13.3.2 Roche Business Overview
13.3.3 Roche Rheumatoid Arthritis Treatment Introduction
13.3.4 Roche Revenue in Rheumatoid Arthritis Treatment Business (2015-2020)
13.3.5 Roche Recent Development
13.4 Johnson & Johnson
13.4.1 Johnson & Johnson Company Details
13.4.2 Johnson & Johnson Business Overview
13.4.3 Johnson & Johnson Rheumatoid Arthritis Treatment Introduction
13.4.4 Johnson & Johnson Revenue in Rheumatoid Arthritis Treatment Business (2015-2020)
13.4.5 Johnson & Johnson Recent Development
13.5 AbbVie
13.5.1 AbbVie Company Details
13.5.2 AbbVie Business Overview
13.5.3 AbbVie Rheumatoid Arthritis Treatment Introduction
13.5.4 AbbVie Revenue in Rheumatoid Arthritis Treatment Business (2015-2020)
13.5.5 AbbVie Recent Development
13.6 Eli Lilly
13.6.1 Eli Lilly Company Details
13.6.2 Eli Lilly Business Overview
13.6.3 Eli Lilly Rheumatoid Arthritis Treatment Introduction
13.6.4 Eli Lilly Revenue in Rheumatoid Arthritis Treatment Business (2015-2020)
13.6.5 Eli Lilly Recent Development
13.7 Amgen
13.7.1 Amgen Company Details
13.7.2 Amgen Business Overview
13.7.3 Amgen Rheumatoid Arthritis Treatment Introduction
13.7.4 Amgen Revenue in Rheumatoid Arthritis Treatment Business (2015-2020)
13.7.5 Amgen Recent Development
13.8 Sobi
13.8.1 Sobi Company Details
13.8.2 Sobi Business Overview
13.8.3 Sobi Rheumatoid Arthritis Treatment Introduction
13.8.4 Sobi Revenue in Rheumatoid Arthritis Treatment Business (2015-2020)
13.8.5 Sobi Recent Development
13.9 Bristol-Myers Squibb
13.9.1 Bristol-Myers Squibb Company Details
13.9.2 Bristol-Myers Squibb Business Overview
13.9.3 Bristol-Myers Squibb Rheumatoid Arthritis Treatment Introduction
13.9.4 Bristol-Myers Squibb Revenue in Rheumatoid Arthritis Treatment Business (2015-2020)
13.9.5 Bristol-Myers Squibb Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Rheumatoid Arthritis Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Rheumatoid Arthritis Treatment Revenue
Table 3. Ranking of Global Top Rheumatoid Arthritis Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Rheumatoid Arthritis Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Symptomatic Treatment
Table 6. Key Players of Intermediate Corticosteroid Therapies
Table 7. Key Players of Disease Modifying Antirheumatic Drug Therapies
Table 8. Global Rheumatoid Arthritis Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Rheumatoid Arthritis Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Rheumatoid Arthritis Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Rheumatoid Arthritis Treatment Market Share by Regions (2015-2020)
Table 12. Global Rheumatoid Arthritis Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Rheumatoid Arthritis Treatment Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Rheumatoid Arthritis Treatment Market Growth Strategy
Table 18. Main Points Interviewed from Key Rheumatoid Arthritis Treatment Players
Table 19. Global Rheumatoid Arthritis Treatment Revenue by Players (2015-2020) (Million US$)
Table 20. Global Rheumatoid Arthritis Treatment Market Share by Players (2015-2020)
Table 21. Global Top Rheumatoid Arthritis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rheumatoid Arthritis Treatment as of 2019)
Table 22. Global Rheumatoid Arthritis Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Rheumatoid Arthritis Treatment Product Solution and Service
Table 25. Date of Enter into Rheumatoid Arthritis Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Rheumatoid Arthritis Treatment Market Size by Type (2015-2020) (Million US$)
Table 28. Global Rheumatoid Arthritis Treatment Market Size Share by Type (2015-2020)
Table 29. Global Rheumatoid Arthritis Treatment Revenue Market Share by Type (2021-2026)
Table 30. Global Rheumatoid Arthritis Treatment Market Size Share by Application (2015-2020)
Table 31. Global Rheumatoid Arthritis Treatment Market Size by Application (2015-2020) (Million US$)
Table 32. Global Rheumatoid Arthritis Treatment Market Size Share by Application (2021-2026)
Table 33. North America Key Players Rheumatoid Arthritis Treatment Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Rheumatoid Arthritis Treatment Market Share (2019-2020)
Table 35. North America Rheumatoid Arthritis Treatment Market Size by Type (2015-2020) (Million US$)
Table 36. North America Rheumatoid Arthritis Treatment Market Share by Type (2015-2020)
Table 37. North America Rheumatoid Arthritis Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. North America Rheumatoid Arthritis Treatment Market Share by Application (2015-2020)
Table 39. Europe Key Players Rheumatoid Arthritis Treatment Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Rheumatoid Arthritis Treatment Market Share (2019-2020)
Table 41. Europe Rheumatoid Arthritis Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Rheumatoid Arthritis Treatment Market Share by Type (2015-2020)
Table 43. Europe Rheumatoid Arthritis Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Rheumatoid Arthritis Treatment Market Share by Application (2015-2020)
Table 45. China Key Players Rheumatoid Arthritis Treatment Revenue (2019-2020) (Million US$)
Table 46. China Key Players Rheumatoid Arthritis Treatment Market Share (2019-2020)
Table 47. China Rheumatoid Arthritis Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. China Rheumatoid Arthritis Treatment Market Share by Type (2015-2020)
Table 49. China Rheumatoid Arthritis Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. China Rheumatoid Arthritis Treatment Market Share by Application (2015-2020)
Table 51. Japan Key Players Rheumatoid Arthritis Treatment Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Rheumatoid Arthritis Treatment Market Share (2019-2020)
Table 53. Japan Rheumatoid Arthritis Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Rheumatoid Arthritis Treatment Market Share by Type (2015-2020)
Table 55. Japan Rheumatoid Arthritis Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Rheumatoid Arthritis Treatment Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Rheumatoid Arthritis Treatment Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Rheumatoid Arthritis Treatment Market Share (2019-2020)
Table 59. Southeast Asia Rheumatoid Arthritis Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Rheumatoid Arthritis Treatment Market Share by Type (2015-2020)
Table 61. Southeast Asia Rheumatoid Arthritis Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Rheumatoid Arthritis Treatment Market Share by Application (2015-2020)
Table 63. India Key Players Rheumatoid Arthritis Treatment Revenue (2019-2020) (Million US$)
Table 64. India Key Players Rheumatoid Arthritis Treatment Market Share (2019-2020)
Table 65. India Rheumatoid Arthritis Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. India Rheumatoid Arthritis Treatment Market Share by Type (2015-2020)
Table 67. India Rheumatoid Arthritis Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. India Rheumatoid Arthritis Treatment Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Rheumatoid Arthritis Treatment Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Rheumatoid Arthritis Treatment Market Share (2019-2020)
Table 71. Central & South America Rheumatoid Arthritis Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Rheumatoid Arthritis Treatment Market Share by Type (2015-2020)
Table 73. Central & South America Rheumatoid Arthritis Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Rheumatoid Arthritis Treatment Market Share by Application (2015-2020)
Table 75. Sanofi Company Details
Table 76. Sanofi Business Overview
Table 77. Sanofi Product
Table 78. Sanofi Revenue in Rheumatoid Arthritis Treatment Business (2015-2020) (Million US$)
Table 79. Sanofi Recent Development
Table 80. Pfizer Company Details
Table 81. Pfizer Business Overview
Table 82. Pfizer Product
Table 83. Pfizer Revenue in Rheumatoid Arthritis Treatment Business (2015-2020) (Million US$)
Table 84. Pfizer Recent Development
Table 85. Roche Company Details
Table 86. Roche Business Overview
Table 87. Roche Product
Table 88. Roche Revenue in Rheumatoid Arthritis Treatment Business (2015-2020) (Million US$)
Table 89. Roche Recent Development
Table 90. Johnson & Johnson Company Details
Table 91. Johnson & Johnson Business Overview
Table 92. Johnson & Johnson Product
Table 93. Johnson & Johnson Revenue in Rheumatoid Arthritis Treatment Business (2015-2020) (Million US$)
Table 94. Johnson & Johnson Recent Development
Table 95. AbbVie Company Details
Table 96. AbbVie Business Overview
Table 97. AbbVie Product
Table 98. AbbVie Revenue in Rheumatoid Arthritis Treatment Business (2015-2020) (Million US$)
Table 99. AbbVie Recent Development
Table 100. Eli Lilly Company Details
Table 101. Eli Lilly Business Overview
Table 102. Eli Lilly Product
Table 103. Eli Lilly Revenue in Rheumatoid Arthritis Treatment Business (2015-2020) (Million US$)
Table 104. Eli Lilly Recent Development
Table 105. Amgen Company Details
Table 106. Amgen Business Overview
Table 107. Amgen Product
Table 108. Amgen Revenue in Rheumatoid Arthritis Treatment Business (2015-2020) (Million US$)
Table 109. Amgen Recent Development
Table 110. Sobi Business Overview
Table 111. Sobi Product
Table 112. Sobi Company Details
Table 113. Sobi Revenue in Rheumatoid Arthritis Treatment Business (2015-2020) (Million US$)
Table 114. Sobi Recent Development
Table 115. Bristol-Myers Squibb Company Details
Table 116. Bristol-Myers Squibb Business Overview
Table 117. Bristol-Myers Squibb Product
Table 118. Bristol-Myers Squibb Revenue in Rheumatoid Arthritis Treatment Business (2015-2020) (Million US$)
Table 119. Bristol-Myers Squibb Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Rheumatoid Arthritis Treatment Market Share by Type: 2020 VS 2026
Figure 2. Symptomatic Treatment Features
Figure 3. Intermediate Corticosteroid Therapies Features
Figure 4. Disease Modifying Antirheumatic Drug Therapies Features
Figure 5. Global Rheumatoid Arthritis Treatment Market Share by Application: 2020 VS 2026
Figure 6. Hospital Pharmacy Case Studies
Figure 7. Retail Pharmacy Case Studies
Figure 8. Drug Stores Case Studies
Figure 9. Rheumatoid Arthritis Treatment Report Years Considered
Figure 10. Global Rheumatoid Arthritis Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Rheumatoid Arthritis Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Rheumatoid Arthritis Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Rheumatoid Arthritis Treatment Market Share by Players in 2019
Figure 15. Global Top Rheumatoid Arthritis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rheumatoid Arthritis Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Rheumatoid Arthritis Treatment Revenue in 2019
Figure 17. North America Rheumatoid Arthritis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Rheumatoid Arthritis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Rheumatoid Arthritis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Rheumatoid Arthritis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Rheumatoid Arthritis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Rheumatoid Arthritis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Rheumatoid Arthritis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed

以下、関連資料のご紹介

関節リウマチ診断検査の世界市場（～2026年）

Global Rheumatoid Arthritis Diagnosis Tests Market Size, Status and Forecast 2020-2026
MRC2-11QY04515 2020年11月20日 90Pages
当調査資料は関節リウマチ診断検査のグローバル市場について調査・分析したレポートです。種類別（血清学検査、RA治療効率検査モニタリング）市場規模、用途別（診断研究所、外来外科センター、病院）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中...

関節リウマチ治療薬の世界市場（～2026年）

Global Rheumatoid Arthritis Drugs Market Insights and Forecast to 2026
MRC2-11QY09117 2020年11月25日 114Pages
当調査資料は関節リウマチ治療薬のグローバル市場について調査・分析したレポートです。種類別（処方薬、市販薬）市場規模、用途別（病院、クリニック、老人ホーム、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オースト...

血清反応陽性用関節リウマチ治療薬の世界市場（～2026年）

Global Seropositive Rheumatoid Arthritis Drug Market Insights and Forecast to 2026
MRC2-11QY09391 2020年11月25日 152Pages
当調査資料は血清反応陽性用関節リウマチ治療薬のグローバル市場について調査・分析したレポートです。種類別（非ステロイド性抗炎症薬、疾患修飾性抗リウマチ治療薬、生物製剤）市場規模、用途別（医療、科学研究、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシ...

全身性特発性若年性関節炎治療の世界市場（～2026年）

Global Systemic Idiopathic Juvenile Arthritis Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04784 2020年11月20日 92Pages
当調査資料は全身性特発性若年性関節炎治療のグローバル市場について調査・分析したレポートです。種類別（アダリムマブバイオシミラー、カナキヌマブ、ゴリムマブ、トシリズマブバイオシミラー、その他）市場規模、用途別（クリニック、病院、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス...

乾癬性関節炎治療の世界市場（～2026年）

Global Psoriatic Arthritis Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04408 2020年11月20日 95Pages
当調査資料は乾癬性関節炎治療のグローバル市場について調査・分析したレポートです。種類別（キット、試薬、器具）市場規模、用途別（病院、診療所、外来手術センター、診断研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、...

関節炎薬の世界市場（～2026年）

Global Arthritis Drug Market Insights and Forecast to 2026
MRC2-11QY02683 2020年11月20日 112Pages
当調査資料は関節炎薬のグローバル市場について調査・分析したレポートです。種類別（合成DMARD、生物学的DMARD、NSAID、コルチコステロイド、鎮痛薬）市場規模、用途別（小売薬局、病院薬局、ドラッグストア、Eコマース）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、...

敗血症性関節炎の世界市場（～2026年）

Global Septic Arthritis Market Size, Status and Forecast 2020-2026
MRC2-11QY04586 2020年11月20日 97Pages
当調査資料は敗血症性関節炎のグローバル市場について調査・分析したレポートです。種類別（診断、治療）市場規模、用途別（整形外科病院、クリニック、診断センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア...

乾癬性関節炎治療薬の世界市場（～2026年）

Global Psoriatic Arthritis Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY04407 2020年11月20日 93Pages
当調査資料は乾癬性関節炎治療薬のグローバル市場について調査・分析したレポートです。種類別（非ステロイド性抗炎症薬、疾患修飾性抗リウマチ薬、生物学的薬剤、酵素阻害剤）市場規模、用途別（病院、診療所、研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、...

クラッベ病治療の世界市場（～2026年）

Global Krabbe Disease Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY12467 2020年11月25日 94Pages
当調査資料はクラッベ病治療のグローバル市場について調査・分析したレポートです。種類別（抗けいれん薬、筋弛緩薬、造血幹細胞移植、その他）市場規模、用途別（病院、ASC）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オー...

アレルギー性鼻炎治療の世界市場（～2026年）

Global Allergic Rhinitis Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY13652 2020年11月30日 91Pages
当調査資料はアレルギー性鼻炎治療のグローバル市場について調査・分析したレポートです。種類別（抗ヒスタミン薬、鼻腔内コルチコステロイド、免疫療法、充血除去薬、その他）市場規模、用途別（季節性アレルギー性鼻炎、通年性アレルギー性鼻炎）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イ...

関節リウマチ診断検査の世界市場（～2026年） Rheumatoid arthritis is a long-term autoimmune disorder that primarily affects joints. The goals of rheumatoid arthritis treatment are to reduce pain, decrease inflammation and improve a person's overall functioning. Market Analysis and Insights: Global Rheumatoid Arthritis Diagnosis Tests Market Th…
血清反応陽性用関節リウマチ治療薬の世界市場（～2026年） Arthritis means inflammation in a joint. The inflammation is characterized by swelling, pain, and redness within the joint. This type of arthritis is known to cause chronic inflammatory disorder in the hands and feet. The Americas dominated the overall market in terms of revenue in 2016 owing to the…
関節リウマチ治療薬の世界市場（～2026年） Rheumatoid Arthritis Drugs include prescription and OTC. The increasing prevalence of arthritis, the increasing acceptance of biopharmaceuticals, and the development of clear regulatory guidelines are major trends that are expected to trigger market growth. Market Analysis and Insights: Global Rheum…
乾癬性関節炎治療の世界市場（～2026年） Market Analysis and Insights: Global Psoriatic Arthritis Treatment Market The global Psoriatic Arthritis Treatment market size is projected to reach US$ 8155.4 million by 2026, from US$ 7679.9 million in 2020, at a CAGR of 5.7%% during 2021-2026. Global Psoriatic Arthritis Treatment Scope and Market…
全身性特発性若年性関節炎治療の世界市場（～2026年） Market Analysis and Insights: Global Systemic Idiopathic Juvenile Arthritis Treatment Market The global Systemic Idiopathic Juvenile Arthritis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Systemic Idiopath…